Göran Engberg

8.3k total citations
114 papers, 5.2k citations indexed

About

Göran Engberg is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience and Behavioral Neuroscience. According to data from OpenAlex, Göran Engberg has authored 114 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Biological Psychiatry, 48 papers in Cellular and Molecular Neuroscience and 35 papers in Behavioral Neuroscience. Recurrent topics in Göran Engberg's work include Tryptophan and brain disorders (63 papers), Neuroscience and Neuropharmacology Research (36 papers) and Stress Responses and Cortisol (35 papers). Göran Engberg is often cited by papers focused on Tryptophan and brain disorders (63 papers), Neuroscience and Neuropharmacology Research (36 papers) and Stress Responses and Cortisol (35 papers). Göran Engberg collaborates with scholars based in Sweden, United States and United Kingdom. Göran Engberg's co-authors include Sophie Erhardt, Lilly Schwieler, Conny Nordin, Hans Nissbrandt, Sara K. Olsson, Leif Lindström, Elisabeth Skogh, Klas R. Linderholm, Torgny H. Svensson and Kaj Blennow and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

Göran Engberg

111 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Göran Engberg Sweden 42 2.9k 1.6k 1.6k 1.4k 1.4k 114 5.2k
Hui‐Qiu Wu United States 31 2.8k 1.0× 1.0k 0.6× 1.6k 1.0× 917 0.7× 909 0.7× 49 3.9k
József Toldi Hungary 38 2.3k 0.8× 1.2k 0.8× 1.3k 0.8× 1.1k 0.8× 1.2k 0.9× 165 5.2k
Sophie Erhardt Sweden 45 4.9k 1.7× 937 0.6× 2.9k 1.8× 2.1k 1.5× 1.2k 0.9× 128 6.9k
Thomas C. Baghai Germany 45 1.5k 0.5× 1.7k 1.0× 1.6k 1.0× 1.3k 0.9× 1.3k 1.0× 170 6.7k
Gabriel R. Fries United States 42 2.3k 0.8× 1.1k 0.7× 963 0.6× 2.0k 1.4× 1.2k 0.9× 144 5.8k
Hooriyah S. Rizavi United States 38 1.5k 0.5× 1.6k 1.0× 1.3k 0.8× 556 0.4× 1.7k 1.2× 58 4.6k
Angelos Halaris United States 36 1.0k 0.3× 2.2k 1.4× 879 0.6× 620 0.4× 1.3k 1.0× 140 5.4k
Cornelius Schüle Germany 42 1.2k 0.4× 1.4k 0.8× 1.5k 0.9× 890 0.6× 879 0.6× 126 5.1k
Maurizio Popoli Italy 47 2.6k 0.9× 3.3k 2.1× 2.3k 1.5× 537 0.4× 1.7k 1.2× 149 7.6k
Andrew Harkin Ireland 42 1.9k 0.7× 1.3k 0.8× 1.5k 0.9× 518 0.4× 857 0.6× 122 4.9k

Countries citing papers authored by Göran Engberg

Since Specialization
Citations

This map shows the geographic impact of Göran Engberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Göran Engberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Göran Engberg more than expected).

Fields of papers citing papers by Göran Engberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Göran Engberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Göran Engberg. The network helps show where Göran Engberg may publish in the future.

Co-authorship network of co-authors of Göran Engberg

This figure shows the co-authorship network connecting the top 25 collaborators of Göran Engberg. A scholar is included among the top collaborators of Göran Engberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Göran Engberg. Göran Engberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orhan, Funda, Neda Khanlarkhani, Marja Koskuvi, et al.. (2025). Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia. American Journal of Psychiatry. 182(4). 389–400.
2.
Tufvesson‐Alm, Maximilian, et al.. (2023). Dual administration of lipopolysaccharide induces behavioural changes in rats relevant to psychotic disorders. Acta Neuropsychiatrica. 37. e18–e18. 3 indexed citations
3.
Engberg, Göran, Fredrik Piehl, Simon Červenka, et al.. (2023). Disrupted‐in‐schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first‐episode psychosis. Psychiatry and Clinical Neurosciences. 77(12). 665–671. 7 indexed citations
4.
Shang, Pei, Ada Man‐Choi Ho, Maximilian Tufvesson‐Alm, et al.. (2022). Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients. Translational Psychiatry. 12(1). 229–229. 13 indexed citations
5.
Sellgren, Carl M., Helena Fatouros‐Bergman, Fredrik Piehl, et al.. (2020). CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects. IBRO Reports. 8. 136–142. 6 indexed citations
6.
Tufvesson‐Alm, Maximilian, Sophie Imbeault, Doo‐Sup Choi, et al.. (2020). Repeated administration of LPS exaggerates amphetamine-induced locomotor response and causes learning deficits in mice. Journal of Neuroimmunology. 349. 577401–577401. 8 indexed citations
7.
Orhan, Funda, Lilly Schwieler, Helena Fatouros‐Bergman, et al.. (2018). Increased number of monocytes and plasma levels ofMCP‐1 andYKL‐40 in first‐episode psychosis. Acta Psychiatrica Scandinavica. 138(5). 432–440. 25 indexed citations
8.
Holmberg, Dag, Richard Idro, Robert O. Opoka, et al.. (2017). Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria. Malaria Journal. 16(1). 303–303. 37 indexed citations
9.
Erhardt, Sophie, et al.. (2016). Decreased levels of kynurenic acid in prefrontal cortex in a genetic animal model of depression. Acta Neuropsychiatrica. 29(1). 54–58. 15 indexed citations
10.
Linderholm, Klas R., Elisabeth Skogh, Sara K. Olsson, et al.. (2010). Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia. Schizophrenia Bulletin. 38(3). 426–432. 249 indexed citations
11.
Erhardt, Sophie, Sara K. Olsson, & Göran Engberg. (2009). Pharmacological Manipulation of Kynurenic Acid. CNS Drugs. 23(2). 91–101. 141 indexed citations
12.
Olsson, Sara K., Klas R. Linderholm, M. Holtze, et al.. (2008). Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia. The International Journal of Neuropsychopharmacology. 12(4). 501–501. 40 indexed citations
13.
Linderholm, Klas R., et al.. (2007). Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: A pharmacological analysis. Neuropharmacology. 53(8). 918–924. 41 indexed citations
14.
15.
Hashimoto, Kenji, Göran Engberg, Eiji Shimizu, et al.. (2005). Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry. 5(1). 6–6. 90 indexed citations
16.
Erhardt, Sophie, et al.. (2001). Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons. Amino Acids. 20(4). 353–362. 59 indexed citations
17.
Erhardt, Sophie, Bengt Åndersson, Hans Nissbrandt, & Göran Engberg. (1998). Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by γ-hydroxybutyric acid (GHBA) are specifically induced by activation of GABAB receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 357(6). 611–619. 52 indexed citations
18.
Nissbrandt, Hans & Göran Engberg. (1996). The GABA B -receptor antagonist, CGP 35348, antagonises ?-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice. Journal of Neural Transmission. 103(11). 1255–1263. 43 indexed citations
19.
Engberg, Göran & Håkan Wikström. (1991). σ-Receptors: Implication for the control of neuronal activity of nigral dopamine-containing neurons. European Journal of Pharmacology. 201(2-3). 199–202. 17 indexed citations
20.
Engberg, Göran. (1989). A metabolite of buspirone increases locus coeruleus activity via alpha2-receptor blockade. Journal of Neural Transmission. 76(2). 91–98. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hui‐Qiu Wu Breakdown of academic impact, for papers by József Toldi Breakdown of academic impact, for papers by Sophie Erhardt Breakdown of academic impact, for papers by Thomas C. Baghai Breakdown of academic impact, for papers by Gabriel R. Fries Breakdown of academic impact, for papers by Hooriyah S. Rizavi Breakdown of academic impact, for papers by Angelos Halaris Breakdown of academic impact, for papers by Cornelius Schüle Breakdown of academic impact, for papers by Maurizio Popoli Breakdown of academic impact, for papers by Andrew Harkin
Rankless by CCL
2026